US Site 29 — Missouri City, Texas

US Site 29 is a clinical research site located in Missouri City, Texas, United States 77459.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

US Site 29 has participated in 1 clinical trials.

Therapeutic areas: Hypertriglyceridemia, Type 2 Diabetes.

Sponsors: Afimmune.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Missouri City

Browse all research sites in Texas · View every site in Missouri City

• Synergy Groups Medical
• GSK Investigational Site
• Discovery MM Services Inc.
• Synergy Groups Medical - Missouri City
• Gulf Coast Medical Research
• Synapse Clinical Research - Missouri City- Site Number : 8401148
• Synergy Research Site
• Research Site
• Sienna Dermatology Research
• Novo Nordisk Investigational Site
• Sienna Dermatology- Site Number : 8401148
• Synergy Group US - Missouri City- Site Number : 8400119

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for US Site 29?

US Site 29 has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has US Site 29 conducted?

US Site 29 has 1 clinical trials on record. Their work covers Hypertriglyceridemia, Type 2 Diabetes.

Is US Site 29 accredited by Crixeo Clinical Trials?

US Site 29 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about US Site 29?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.